FDA approves Acer’s olpruva to treat urea cycle disorders

FDA approves Acer’s olpruva to treat urea cycle disorders

Submitted by admin on December 28, 2022 - 8:34pm
Source: 
Pharmaceutical Business Review
News Tags: 
FDA
Acer Therapeutics
olpruva
urea cycle disorders
Headline: 
FDA approves Acer’s olpruva to treat urea cycle disorders
snippet: 

The US Food and Drug Administration (FDA) has approved Acer Therapeutics’ olpruva (sodium phenylbutyrate) to treat patients with urea cycle disorders (UCDs).

Do Not Allow Advertisers to Use My Personal information